Literature DB >> 27503284

Comment on: "Safety and Tolerability of Pharmacological Treatment of Alcohol Dependence: Comprehensive Review of Evidence".

Alain Braillon1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2016        PMID： 27503284     DOI： 10.1007/s40264-016-0447-4

Source DB:  PubMed          Journal:  Drug Saf        ISSN： 0114-5916            Impact factor:   5.606


× No keyword cloud information.
  11 in total

1.  Nalmefene in alcohol misuse: junk evaluation by the European Medicines Agency.

Authors:  Alain Braillon
Journal:  BMJ       Date:  2014-03-10

Review 2.  Bad medicine: nalmefene in alcohol misuse.

Authors:  Des Spence
Journal:  BMJ       Date:  2014-02-14

3.  Cost-Effectiveness of Nalmefene: Exaggerated Expectations or Fallacy?

Authors:  Florian Naudet; Bernard Granger; Alain Braillon
Journal:  Alcohol Alcohol       Date:  2016-06-03       Impact factor: 2.826

4.  [Manic symptoms induced by high doses of baclofen: A case report].

Authors:  F Rivollier; M Masson
Journal:  Encephale       Date:  2016-06-09       Impact factor: 1.291

5.  Off-Label Drug Use: Whose Interests Are Served?

Authors:  Alain Braillon; Joel Lexchin
Journal:  Am J Med Qual       Date:  2016-02-25       Impact factor: 1.852

Review 6.  Managed alcohol as a harm reduction intervention for alcohol addiction in populations at high risk for substance abuse.

Authors:  Wendy Muckle; Jamie Muckle; Vivian Welch; Peter Tugwell
Journal:  Cochrane Database Syst Rev       Date:  2012-12-12

7.  Severe Central Sleep Apnea Associated With Chronic Baclofen Therapy: A Case Series.

Authors:  Pierre-Yves Olivier; Marie Joyeux-Faure; Thibaut Gentina; Sandrine H Launois; Marie Pia d'Ortho; Jean-Louis Pépin; Frédéric Gagnadoux
Journal:  Chest       Date:  2016-05       Impact factor: 9.410

Review 8.  Safety and Tolerability of Pharmacological Treatment of Alcohol Dependence: Comprehensive Review of Evidence.

Authors:  Julia M A Sinclair; Sophia E Chambers; Celia J Shiles; David S Baldwin
Journal:  Drug Saf       Date:  2016-07       Impact factor: 5.606

9.  Nalmefene and alcohol dependence: A new approach or the same old unacceptable marketing?

Authors:  Alain Braillon; Bernard Granger
Journal:  Subst Abuse Rehabil       Date:  2015-06-29

Review 10.  Weak evidence on nalmefene creates dilemmas for clinicians and poses questions for regulators and researchers.

Authors:  Niamh Fitzgerald; Kathryn Angus; Andrew Elders; Marisa de Andrade; Duncan Raistrick; Nick Heather; Jim McCambridge
Journal:  Addiction       Date:  2016-06-05       Impact factor: 6.526
View more
  1 in total

1.  Authors' Reply to Alain Braillon's Comment on "Safety and Tolerability of Pharmacological Treatment of Alcohol Dependence: Comprehensive Review of Evidence".

Authors:  Julia M A Sinclair; Sophia E Chambers; David S Baldwin
Journal:  Drug Saf       Date:  2016-11       Impact factor: 5.606
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.